The Risks of Percutaneous Native Kidney Biopsy in Italy: a Prospective Cohort Study
NCT ID: NCT04948593
Last Updated: 2021-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5304 participants
OBSERVATIONAL
2012-01-03
2021-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy
NCT00748072
Non-invasive Diagnosis of Idiopathic Nephrotic Syndromes
NCT06820866
Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions
NCT02468401
Renal PRotection Against Contrast mEdium-induced nephroPathy in High Risk Patients undErgoing Coronary Angiography
NCT02463604
Aminophylline and Contrast Induced Nephropathy in Acute Myocardial Infarction
NCT01594489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary outcome of the study was any major complication, such as haemoglobin decrease more than 2 g/dL, macroematuria, gross ematoma, blood transfusion, artero-venous fistula, invasive intervention, pain, symptomatic hypotension, and/or rapid serum creatinine increase.
Centre and individual patient risk predictors were analysed using multivariate logistic regression analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Native kidney biopsy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* informed Consent
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Simeone Andrulli, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simeone Andrulli, MD
Simeone Andrulli, MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
San Giovanni di Dio Hospital
Agrigento, , Italy
Giovanni XXIII pediatric Hospital
Bari, , Italy
Policlinico Hospital
Bari, , Italy
S. Orsola Hospital
Bologna, , Italy
Cannizzaro Hospital
Catania, , Italy
S. Camillo Hospital
Chieti, , Italy
Santa Croce Hospital
Cuneo, , Italy
Maria SS. Addolorata Hospital
Eboli, , Italy
University Hospital
Foggia, , Italy
Policlinico Hospital
Messina, , Italy
Cervello Hospital
Palermo, , Italy
Riuniti Hospital
Parma, , Italy
Ospedali Riuniti Marche Nord Hospital
Pesaro, , Italy
Cisanello Hospital
Pisa, , Italy
Umberto 1° Hospital
Roma, , Italy
Istituto Clinico Humanitas
Rozzano, , Italy
Sollievo Sofferenza Hospital
San Giovanni Rotondo, , Italy
Belcolle Hospital
Viterbo, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Italian Registry Renal Biopsy
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KidneyBiopsyRisk in Italy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.